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Eph proteins are receptor tyrosine kinases that control changes in cell shape and migration during development. We now describe a critical role
for EphA3 receptor signaling in heart development as revealed by the phenotype of EphA3 null mice. During heart development mesenchymal
outgrowths, the atrioventricular endocardial cushions, form in the atrioventricular canal. This morphogenetic event requires endocardial cushion
cells to undergo an epithelial to mesenchymal transformation (EMT), and results in the formation of the atrioventricular valves and membranous
portions of the atrial and ventricular septa. We show that EphA3 knockouts have significant defects in the development of their atrial septa and
atrioventricular endocardial cushions, and that these cardiac abnormalities lead to the death of approximately 75% of homozygous EphA3−/−
mutants. We demonstrate that EphA3 and its ligand, ephrin-A1, are expressed in adjacent cells in the developing endocardial cushions. We further
demonstrate that EphA3−/− atrioventricular endocardial cushions are hypoplastic compared to wildtype and that EphA3−/− endocardial cushion
explants give rise to fewer migrating mesenchymal cells than wildtype explants. Thus our results indicate that EphA3 plays a crucial role in the
development and morphogenesis of the cells that give rise to the atrioventricular valves and septa.
© 2006 Elsevier Inc. All rights reserved.Keywords: Eph; Ephrin; Endocardial cushion; Atrial septum; Heart development; EMTIntroduction
Eph receptors constitute the largest subfamily of receptor
tyrosine kinases by far (Klein, 2001; Noren and Pasquale, 2004;
Wilkinson, 2000). Clustering and activation of Eph receptors
occur upon binding to their membrane-bound ephrin ligands
(Davis et al., 1994). A strikingly complementary pattern of
expression between Ephs and ephrins in apposed cellular
compartments has been observed in the developing rhombo-
meres (Cooke and Moens, 2002), along neural crest migration
pathways (Krull et al., 1997) and in tissues throughout the entire
developing mouse embryo (Gale et al., 1996). There is also now
considerable biochemical and genetic evidence for bi-direc-
tional signaling between Eph proteins and the ephrins, with the
latter acting as signaling ‘receptors’, such that Eph/ephrin
engagement activates signaling pathways in both interacting
cells (Huai and Drescher, 2001; Mellitzer et al., 1999; Xu et al.,
1999).⁎ Corresponding author.
E-mail address: abrown@robarts.ca (A. Brown).
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doi:10.1016/j.ydbio.2006.08.058In contrast to most other receptor tyrosine kinases, activation
of Eph receptors does not typically lead to a proliferative
response in receptor-expressing cells, but rather to changes in
cell shape and movement (Klein, 2001). Eph receptors and
ephrins have been extensively characterized as mediating axon-
repelling events (Drescher et al., 1995; Winslow et al., 1995),
but have also been shown to provide attractive signals (Knoll
et al., 2001) and signals that mediate cell adhesion (Davy and
Robbins, 2000; Lawrenson et al., 2002; Miao et al., 2000). A
large body of evidence supports a role for Eph receptors and
ephrins in axon guidance (Brown et al., 2000; Knoll and
Drescher, 2002; Wilkinson, 2000), neural tube closure (Holm-
berg et al., 2000), neural crest migration (Krull, 1998), vascular
(Adams et al., 1999), and notochord development (Naruse-
Nakajima et al., 2001). Indeed, the evolutionary expansion of
Eph receptors and ephrin ligands, has led to the speculation that
these receptors and ligands must play important and specialized
roles in patterning the vertebrate body plan (Boyd and
Lackmann, 2001).
We have previously reported that EphA3 is expressed in the
embryonic brain, spinal cord, musculature, lungs, and kidneys,
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et al., 1996). In order to study the role of EphA3 in
neurodevelopment, we generated an EphA3 null mutant by
homologous recombination in embryonic stem (ES) cells. These
EphA3−/− mice failed to demonstrate abnormalities in motor
neuron projection patterns but did show an increased perinatal
mortality (Vaidya et al., 2003). We now report that EphA3 and
ephrin-A1 are expressed in adjacent cells of the developing
mouse heart, and that EphA3−/− mice develop debilitating
endocardial cushion and atrial septal defects that lead to death in
most mutants. Thus, EphA3 signaling has a previously
unrecognized yet important role in cardiogenesis.
Materials and methods
Embryo and organ collection
Timed mouse mating were established with the morning of a vaginal plug
defined as E0.5. For all analyses, to minimize the possible confounding
contribution of slight differences in developmental age of wildtype and
EphA3−/− embryos, at least 9 wildtype and 9 EphA3−/− mutants (3 embryos
from 3 different litters) were analyzed. Embryonic age was verified by
staging the embryos by development of the fore- and hindlimb paddles.
RNA in situ hybridization
E12.5 and E11 wildtype embryos were isolated and submersion fixed in 4%
paraformaldehyde overnight. Hybridization was performed following published
protocols (Schaeren-Wiemers and Gerfin-Moser, 1993). The EphA3 probe was a
900-bp fragment from the 5′end of the gene (Kilpatrick et al., 1996); the ephrin-
A1 probe was a 337-bp fragment (nucleotides 328–665); the NF-ATc probe was
a 387-bp fragment (nucleotides 546–933) and the Sox4 probe was a 338-bp
fragment (nucleotides 328–666).
Electrocardiograms
Electrocardiograms were performed on wildtype and EphA3−/− perinatal
mice. Electrodes were inserted subcutaneously in the right and left forearms and
in the left hindlimb. Recordings were taken with a Grass Polygraph and the data
analyzed using Powerlab software (AD Instruments, Mountain View,
California).
Morphometric analysis of endocardial cushion volume
measurements
Fluorescent images of phalloidin–rhodamine (Sigma)-stained serial sec-
tions (10 μm) through the entire atrioventricular cushion and ventricles were
taken using Q Capture (DB2®) software. The atrioventricular endocardial
cushion and ventricular regions were outlined and their cross sectional areas
quantified using Image Pro Plus software. Volumes were computed as the sum
of the product of cross sectional area and section thickness. Data are expressed
as mean±SEM.
Cell counts in endocardial cushions
Five consecutive 10 μm serial sections from the middle of each wildtype and
EphA3−/− atrioventricular endocardial cushion were stained with phalloidin–
rhodamine to delineate the extent of the endocardial cushions and DAPI (4,6
diamino-2-phenylindole, Sigma) to visualize the cell nuclei. Fluorescent images
were taken with Q Capture software (DB2®) and the nuclei in the
atrioventricular endocardial cushion were counted by a blinded observer
(crude counts). Abercrombie's equation was applied to the crude cell counts to
correct for double cell counting (Abercrombie, 1946). The difference between
wildtype and EphA3−/− cushion cell numbers was analyzed using the Student'st-test, with P<0.05 designated as the level of statistical significance. Data are
expressed as mean±SEM.
Cell density
Serial sections through entire wildtype and EphA3−/− atrioventricular
endocardial cushions were stained with phalloidin–rhodamine to delineate the
extent of the endocardial cushions and DAPI to visualize the cell nuclei.
Fluorescent images were taken with Q Capture software (DB2®). Image Pro
Plus software was used to quantify the area of DAPI fluorescence per cushion
area. The percentages of DAPI fluorescence per unit area in the endocardial
cushions of wildtype and EphA3−/− were compared as a relative measure of cell
density. Statistical significance was assessed by the Student's t-test using a
significance level of P<0.05. Data are represented as mean±SEM.
Filamentous actin staining
To visualize filamentous actin, E12.5 wildtype and EphA3−/− atrioventric-
ular endocardial cushion sections (20 μm) were fixed in 4% formaldehyde in
PBS for 20 min at room temperature. Sections were permeabilized with 0.5%
Triton X-100 in PBS for 5 min, blocked with 10% FBS in PBS and stained with
0.1 mg/ml phalloidin–rodamine for 1 h.
3D collagen gel migration assay
Atrioventricular explant cultures were performed as described (Bernanke
and Markwald, 1982). Briefly, the entire atrioventricular canal and outflow
tracts, including the adjacent myocardium, from wildtype and EphA3−/− E10.5
embryos were microdissected with tungsten needles and explanted onto a
drained type I collagen gel (Collaborative Research). Ventricles were also
microdissected and used as negative control explants. Cultures were examined
and scored for mesenchymal cell invasion at 48 and 72 h using an inverted
microscope with Hoffman optics. To identify migrating mesenchymal cells the
microscope was focused on the surface of the gel and gradually adjusted to focus
at increasing depths within the gel. The primary criterion used to identify
migrating mesenchymal cells was the appearance of cells with characteristic
spindle-shaped appearance below the surface of the gel (Runyan and Markwald,
1983). A blinded observer counted the number of mesenchymal cells that
invaded the gel and the difference between wildtype and EphA3−/− explants was
analyzed using the Student's t-test, with P<0.05 designated as the level of
statistical significance. Data are expressed as mean±SEM.
Cell proliferation assay
Pregnant mice were given intraperitoneal injections with 100 μg/g body
weight BrdU (Roche Applied Science) 1 h prior to sacrifice. Five consecutive
transverse cryostat sections through the central region of each embryo's
atrioventricular endocardial cushion were processed for immunohistochemistry
using an anti-BrdU monoclonal antibody (Roche Applied Science) and signal
visualized with a DAB reaction. Sections were counterstained with DAPI. DAB-
andDAPI-positive nuclei were counted and expressed as a percentage of the total
number of nuclei within each section. The data are expressed as mean±SEM.
Student's t-test was used for data comparison, with P<0.05 designated as the
level of statistical significance.
Apoptosis (TUNEL) assay
Apoptotic cells were detected on five consecutive 10 μm cryostat sections
using amodified TUNEL technique (Cregan et al., 1999) by specific end-labeling
of fragmented nuclear DNAwith biotin–dUTP (Roche Applied Science). Biotin-
labeled fragmented DNA was detected with Streptavidin-Alexa488 (Vector
laboratories). Sections were counterstained with DAPI and the number of
TUNEL-positive nuclei was counted and expressed as a percentage of the total
number of nuclei within each section. The data are expressed as mean±SEM.
Student's t-test was used for data comparison, with P<0.05 designated as the
level of statistical significance.
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EphA3 null mutants die perinatally due to cardiac failure
We generated a line of mice that carry a null mutation in the
EphA3 gene. The construct design and screening strategy has
been previously reported (Vaidya et al., 2003). Chimeric
founder mice that transmitted the targeted allele were bred to
129S3Svimj mice allowing us to analyze the mutants on a pure
genetic background. We observed that approximately 75% ofFig. 1. Pathololgical examination of wildtype and EphA3−/− P0 hearts, lungs and l
enlarged, blood-filled atria. (E–H) Consistent with the presence of high cardiac filling
in EphA3−/− lungs (E, F) and livers (G, H). Note specifically the presence of blood in
(B) The cardiac performance of EphA3−/−mice was investigated by electrocardiograp
have a substantial bradycardia and a prolonged PR interval. RA, right atrium; LA
knockout. Scale bar 1.0 mm.homozygous EphA3−/− mice die within the first 2 days of life.
Although the EphA3−/− newborns appeared to be well formed
and to feed after birth, they quickly became cyanotic, and
lethargic. At postmortem examination, the most obvious
abnormality observed in these mice was the enlargement of
their atria (Figs. 1A, C, D) which were engorged with blood and
dilated. The atrial dilatation suggested high cardiac filling
pressures in EphA3−/− hearts. To evaluate the possibility of
increased venous congestion that would be expected in the face
of high cardiac filling pressures, we examined EphA3−/− andivers. (A, C, D) At postmortem examination, EphA3−/− P0 hearts have grossly
pressures in EphA3−/−mice, histological examination revealed blood congestion
the alveoli of EphA3−/− lungs and the venous congestion in the EphA3−/− livers.
hy. Compared to age-matched wildtype mice (N=6), the EphA3−/−mice (N=11)
, left atrium; RV, right ventricle; LV, left ventricle; WT, wildtype; KO, EphA3
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revealed that the neonatal EphA3−/− lungs were poorly inflated
and that their alveoli were blood-filled (Figs. 1E, F). The blood
present in EphA3−/− lungs is an indication of exceedingly high
cardiac filling pressures leading to capillary disruption.
Significantly, EphA3−/− livers were also congested with blood
as compared to wildtype (Figs. 1G, H). Though we have
previously reported that EphA3 is also expressed in the
developing brain, spinal cord, lungs, kidneys and muscle
(Kilpatrick et al., 1996), none of these organs showed obvious
defects in the EphA3−/− mutants (aside from venous congestion)
as assessed by histology.
Cardiac dysfunction in EphA3−/− mutants
Given that our analysis suggested that the EphA3−/− P0
animals were dying of cardiac failure, we investigated their
cardiac performance by carrying out electrocardiography on
wildtype (N=6) and EphA3−/− (N=11) P0 mice. ECGs were
analyzed for mean heart rate (HR), PR interval (atrial and AV
nodal conduction time), QRS interval (ventricular depolariza-
tion time), and Q–T interval (a surrogate of action potential
duration). EphA3−/− mice were found to have a significant
bradycardia and first-degree atrioventricular (AV) block (as
evidenced by a prolonged PR interval) compared to wildtype
mice. EphA3−/− mice had an average heart rate of 297±
17.9 bpm while wildtype mice had an average heart rate of
396±16.3 bpm. The average PR interval (the interval between
the start of the P wave and the beginning of the QRS complex)
for EphA3−/− mice was 0.06±0.006 s compared to 0.04±0.005
s in wildtype mice (Fig. 1B). EphA3−/− ECGs did not reveal
evidence of arrhythmia or of second- or third-degree AV
conduction block.
Atrioventricular canal and septal defects in EphA3−/− mutants
Hearts from EphA3−/− P0 animals (N=16) that became
cyanotic after birth were compared by histological analysis to
age- and genetic background-matched wildtype P0 hearts
(N=10). The most striking feature of the mutant hearts was
their high degree of atrial dilatation and blood engorgement when
compared to wildtype (Figs. 1,2). A possible explanation for this
finding lies in the histological observation of annular dilatation in
the atrioventricular valves of the EphA3 knockout mice. While
wildtype left and right atrioventricular orifices were narrow and
filled by their valvular leaflets,EphA3−/− atrioventricular orifices
were enlarged and their valvular leaflets inadequate to close the
right and left atrioventricular canals (Figs. 2A–D). To ensure that
the annular dilatation seen in EphA3−/− atrioventricular valves
was not due to the plane of section, we examined all serial
sections from the wildtype and EphA3−/− P0 animals processed.
In no case did we find EphA3−/− atrioventricular valves that were
competent to close or whose leaflets overlapped as seen in
wildtype sections.
The atrioventricular septum, the septum separating the right
atrium from the left ventricle, was also found to be much thinner
in the EphA3 null animals than in wildtype (Figs. 2A–D). TheP0 mutants that became cyanotic were also found to have a
pronounced atrial septal defect (Figs. 2E, F). The atrial septum
is composed of a septum primum and a septum secundum (an
infolding of the dorsal wall of the atria). While an infolding
representing the septum secundum was occasionally observed
in EphA3−/− sections, the septum primum was either totally
absent or was represented by only a thin remnant. Atrioven-
tricular valve dilatation and septal defects were also readily
observed in E16.5 EphA3−/− embryos (Figs. 2H, I).
EphA3 and ephrin-A1 expression in the developing heart
In order to understand the cardiac defects in the newborn
EphA3−/− animals, we analyzed EphA3 expression during
cardiogenesis. Using RNA in situ hybridization, we detected
EphA3 mRNA as early as E10.5 in the developing atrioven-
tricular (Fig. 3A) and outflow tract endocardial cushions
(Fig. 3C), and in the mesenchymal cap of the developing
septum primum at E12.5 (Fig. 3B). The endocardial cushions
are mesenchymal structures that give rise to the atrioventricular
valves and septa (Webb et al., 1998). RNA in situ hybridizations
for EphA1, A2, A4, A5, A6, A7 and A8 on sections of E12.5
embryos failed to reveal cardiac expression of these EphA
receptors.
Eph receptors have been shown in other systems to exert
their effects by interacting with their cell surface bound
ligands, often in apposed cell populations. (Gale and
Yancopoulos, 1997; Gilardi-Hebenstreit et al., 1992; Smith
et al., 1997). We therefore performed RNA in situ hybridiza-
tions at E12.5, using anti-sense riboprobes to each of the
ephrin-A ligands (ephrin-A1,-A2,-A3,-A4 and -A5). Only
eprhin-A1 showed cardiac expression at this developmental
time-point. We found that ephrin-A1 is specifically expressed
in a set of cells that are closely apposed to cells expressing
EphA3 in both the developing outflow tract (Figs. 3C, D)
and in the atrioventricular endocardial cushions (Figs. 3B, E,
G). To identify the EphA3 and ephrin-A1-expressing cells,
RNA in situ hybridizations were also carried out on serial
cross sections of E12.5 hearts using riboprobes to Sox4, a gene
expressed throughout the endocardial cushions (Marco et al.,
1998), and to NF-ATc, a marker of the endothelial lining of the
endocardial cushions (Pompa et al., 1998; Ranger et al., 1998)
(Figs. 3F, H). These expression studies demonstrated that
EphA3 is expressed in the mesenchymal cells of the
endocardial cushions, while ephrin-A1 is expressed in cells
of the surrounding endothelial lining.
EphA3−/− endocardial cushions are hypoplastic
As described above, the annuli of the atrioventricular valves
in P0 EphA3−/− mice were dilated and their atrioventricular
septa hypoplastic. To determine if the EphA3−/− endocardial
cushions that give rise to these valves were hypoplastic we
measured the volume of the endocardial cushions from wildtype
and EphA3−/− E12.5 embryos. Morphometric analyses demon-
strated that EphA3−/− cushions were 28.8% smaller (P<0.05)
than wildtype (Figs. 4A, D, G). To investigate whether this
Fig. 2. Atrioventricular junction and septal abnormalities in EphA3−/− mutants. (A–D) The atrioventricular valves of P0 EphA3−/− mice (B, D) that become
cyanotic and lethargic demonstrate abnormal morphology compared to wildtype controls (A, C). Note the annular dilatation (enlarged orifices) of the
atrioventricular valves in the EphA3−/− mice and that the atrioventricular septum is much thinner in EphA3−/− mice than in the wildtype controls. (E, F) These
EphA3−/− mice also demonstrate the almost total absence of an atrial septum that is made up of the septum primum and septum secundum. (G, H) E16.5
EphA3−/− embryos also show atrioventricular annular dilatation and reduction in the thickness of the atrioventricular septum. AVS, atrioventricular septum; RA,
right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle; SL, septal leaflet; ML, mural leaflet; Sp, septum primum; Ss, septum secundum; WT,
wildtype; KO, EphA3 knockout. Scale bar 0.1 mm.
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EphA3−/− endocardial cushions, we measured the area of DAPI
immunofluorescence per unit area of the endocardial cushion as
an indication of cell density over the entire endocardial cushion
in the wildtype and EphA3−/− embryos. This analysis indicated
that the cell densities in wildtype and EphA3−/− endocardial
cushions were not significantly different from each other andthat therefore the number of cells in EphA3−/− endocardial
cushions must be approximately 28.8% lower than in wildtype.
A direct cell count from the central portion of each endocardial
cushion from these same embryos verified that the number of
endocardial cushion cells per section was reduced by 29% in
EphA3−/− embryos (Figs. 4B, E, H). To investigate whether the
entire EphA3−/− heart was smaller than wildtype we measured
Fig. 3. RNA in situ hybridization demonstrates that EphA3 and ephrin-A1 are expressed in the developing endocardial cushion tissue. (A) Darkfield micrograph of an
E10.5 sagittal section through the heart, after hybridization with an anti-EphA3 riboprobe. Strong expression is visible in the endocardial cushions of the developing
atrioventricular canal. (B) This section, through an E12.5 embryo, is counterstained with DAPI and the silver grains viewed under darkfield illumination with a red
filter so that the tissue appears blue while the silver grains, indicating EphA3 expression, appear red. This RNA in situ hybridization demonstrates that EphA3 is highly
expressed in the developing endocardial cushion (EC), and in the mesenchymal cap (MC) on the growing septum primum. (C, D) Serial sagittal sections showing the
outflow tract of an E12.5 mouse heart hybridized with anti-sense EphA3 and ephrin-A1 digoxigenin-labeled riboprobes. Note that the ephrin-A1-expressing cells in
panel D (indicated by the red arrows) are directly adjacent to the EphA3-expressing cells in panel C (indicated by the black arrows). (E–H) Darkfield illumination of
serial cross sections that were hybridized with EphA3 (E), Sox4 (F), ephrin-A1 (G) and NF-ATc (H) demonstrate that while ephrin-A1 is expressed in the NF-ATc-
positive endothelial lining of the endocardial cushions, EphA3 is expressed in the adjacent Sox4-positive mesenchymal cells. At, atria; EC, endocardial cushion tissue;
MC, mesenchymal cap of the growing atrial septum primum; Oft, outflow tract; RV, right ventricle: LV, left ventricle; V, ventricle. Scale bar 0.1 mm.
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wildtype embryos (Figs.4C, F, I). This analysis demonstrated
that there was no significant difference in ventricular volumes
between EphA3−/− and wildtype hearts.Delayed fusion of EphA3−/− endocardial cushions
In the atrioventricular canal region, both an inferior (dorsal)
endocardial cushion and a superior (ventral) endocardial
Fig. 4. EphA3−/− atrioventricular endocardial cushions are hypoplastic. Histological sections through the entire atrioventricular endocardial cushions of E12.5 wildtype
(N=9) and EphA3−/− (N=9) embryos were stained with phalloidin–rhodamine to delineate the extent of the cushions in each section (dashed outlines in A, B, D, E)
and with DAPI, to delineate cell nuclei. (A, D, G) The average volume of EphA3−/− atrioventricular endocardial cushions is 28.8% smaller than wildtype. (B, E, H)
Sections from the middle 25% of the endocardial cushions were counterstained with DAPI (after the phalloidin–rhodamine staining) and endocardial cushion cell
nuclei counted. The average number of cells per section through the middle of EphA3−/− atrioventricular endocardial cushions is 29% lower than wildtype. (C, F, I) The
ventricular area (outlined with a dashed line) in each phalloidin–rhodamine-stained section was also measured using Image Pro Plus software and the average
ventricular volume of wildtype and EphA3−/− hearts calculated. There is no significant difference in ventricular volumes between wildtype and EphA3−/− hearts. EC,
endocardial cushion tissue; WT, wildtype; KO, EphA3 knockout; IVS, interventricular septum. Scale bar 0.1 mm.
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growth and fusion of the two cushions produce a central
mesenchymal mass by E11.5 in the mouse, which is further
remodeled to form the mature mitral and tricuspid valves and
atrioventricular septum. Since EphA3−/− atrioventricular endo-
cardial cushions are hypoplastic, less tissue is available to span
the atrioventricular canal than in wildtype hearts. Thus we
predicted that atrioventricular endocardial cushion fusion would
be delayed in EphA3−/− hearts. On examination, 75% (9/12) of
EphA3−/− E11.5 atrioventricular endocardial cushions were notyet fused whereas all (14/14) wildtype atrioventricular endo-
cardial cushions were fused by this time (Figs. 5A, B).
EMT and migration in EphA3−/− endocardial cushions
Within the atrioventricular canal a subpopulation of
endothelial cells undergo an EMT to form the endocardial
cushion. During the EMT these cells undergo morphological
changes as they lose cell–cell adhesions, extend filopodia and
migrate into the extracellular matrix separating the endothelium
Fig. 5. Atrioventricular endocardial cushion fusion and cellular morphology is abnormal in EphA3−/− embryos. (A, B) Hematoxylin and eosin-stained E11.5 wildtype
and EphA3−/− cross sections demonstrate that there is a delay in atrioventricular endocardial cushion fusion in approximately 75% (9/12) EphA3−/− embryos. (C–F)
Hematoxylin and eosin-stained E12.5 wildtype and EphA3−/− endocardial cushion cells. The areas magnified in panels D and F correspond to the boxed areas in panels
C and E, respectively. Note that the wildtype endocardial cushion cells have a flattened morphology with many cellular protrusions and extensions that appear to
connect neighboring cells (N=18). On the other hand, in 14 of the 18 EphA3−/− embryos examined the endocardial cushion cells, appeared rounded-up and to have few
cellular extensions. IC, inferior endocardial cushion tissue; SC, superior endocardial cushion tissue; WT, wildtype; KO, EphA3 knockout. Scale bar in panels A and B,
0.1 mm. Scale bar in panels C–F, 0.01 mm.
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histological examination of wildtype atrioventricular endocar-
dial cushions demonstrated flattened cells with multiple
processes that were aligned in the same direction and extended
to neighboring cells (Figs. 5C, D). EphA3−/− atrioventricular
endocardial cushion cells, on the other hand, appeared rounded-
up with few or no processes (Figs. 5E, F). This abnormal cellular
morphology was seen in 78% (14/18) of the E12.5 EphA3−/−
embryos examined. To further characterize the lack of cellular
processes and alignment in EphA3−/− endocardial cushion cells
we used phalloidin staining of wildtype and EphA3−/− sectionsto visualize filamentous actin (F-actin) (Zhao and Rivkees,
2004). Endocardial cushion cells from E12.5 wildtype embryos
exhibited long, well-defined actin stress fibers that aligned with
each other in a radial orientation (at approximately right angles
to the endocardial cushion surface), whereas endocardial cells
from the E12.5 EphA3−/− embryos that demonstrated the
rounded-up morphology either had fewer stress fibers (weaker
phalloidin staining) or stress fibers that were shorter than
wildtype and not aligned between cells (Fig. 6).
We used an ex vivo explant assay to compare the ability of
wildtype and EphA3−/− endocardial cushion explants to generate
Fig. 6. Stress fibers in EphA3−/− endocardial cushion cells are reduced in size and disorganized. Sections of E12.5 wildtype (N=18) and EphA3−/− (N=18) hearts were
stained with a phalloidin–rhodamine conjugate to reveal the pattern of F-actin in the endocardial cushion cells. (A, B) Stress fibers in wildtype atrioventricular
endocardial cushion cells are long, appear almost continuous between cells and to be arranged in a roughly parallel alignment at right angles to the surface of the
endocardial cushion. (C, D) In the majority of EphA3−/− endocardial cushions stress fibers as evidenced by phalloidin staining could not be demonstrated. (E, F) In the
minority of cases in which phalloidin staining revealed stress fibers in EphA3−/− endocardial cushion cells the fibers were short and appeared to be oriented randomly
relative to the surface of the endocardial cushion and to other endocardial cushion cells. The areas magnified in panels B, D and E correspond to the boxed areas in
panels A, C and E respectively. EC, endocardial cushion tissue; IVS, interventricular septum; WT, wildtype; KO, EphA3 knockout. Scale bar in panels A and C,
0.5 mm. Scale in bar in panels B and D, 0.01 mm.
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This assay has been a key tool in the study of EMT in the
endocardial cushion (Nakajima et al., 2000). We performed
microdissections of E10.5 wildtype (N=16) and EphA3−/−
(N=12) hearts and separately explanted their ventricles, whole
atrioventricular canals and outflow tracts with attached overlying
myocardium onto collagen gels. In atrioventricular canal
explants, by 48 h a subset of endothelial cells transform into
spindle-shaped mesenchymal cells that migrate laterally andinvade the collagen gel. Approximately 17± 0.6 and 24±1
wildtype mesenchymal cells migrated into the gel after 48 and 72
h, respectively (Figs. 7A–C). In the EphA3−/− atrioventricular
canal explants, the number of mesenchymal cells that invaded the
collagen gel was significantly reduced (approximately 9±0.5 and
16±0.6 mesenchymal cells were scored after 48 and 72 h,
respectively). There was no difference in the number of cells
migrating into the collagen gel in wildtype andEphA3−/− outflow
tract explants and no cells were observed to migrate into the
Fig. 7. EMT is reduced in EphA3−/− endocardial cushion cells. (A, B, C) Endocardial cushion explants from E10.5 (A) wildtype (N=16) and (B) KO (N=12) embryos
were seeded onto type I collagen gels and the number of cells migrating into the collagen gel scored. The migrating cells were beneath the surface of the gel and had a
typical spin-shaped appearance (arrows). There are significantly fewer migrating cells scored in EphA3−/− endocardial cushion explants (Student's t-test, P<0.05). (D,
E, F) Proliferating cells were identified in sections of wildtype (N=10) and EphA3−/− (N=9) atrioventricular endocardial cushions by BrdU incorporation. Cells in the
S-phase of mitosis were identified by anti-BrdU immunohistochemistry using a DAB reaction. There is no significant difference in the number of BrdU-labeled
endocardial cushion cells between wildtype and EphA3−/− embryos. (G, H, I) Cells undergoing apoptosis were identified in sections of wildtype (N=9) and EphA3−/−
(N=9) atrioventricular endocardial cushions by TUNEL staining. The sections were counterstained with DAPI to facilitate scoring of apoptotic nuclei. Insets in panels
G and H are approximately 2-fold magnifications of the boxed regions in these panels. Almost all apoptotic nuclei were confined to the medial region of the
endocardial cushion where the atrial septum fuses with the central mesenchymal mass. The percentage of apoptotic nuclei though low was greater in this region in
EphA3−/− endocardial cushions compared to wildtype (Student's t-test, P<0.05). EC, endocardial cushion tissue; IVS, interventricular septum; WT, wildtype; KO,
EphA3 knockout. Scale bar 0.1 mm.
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ventricular explants (data not shown).
Proliferation and apoptosis in EphA3−/− atrioventricular
endocardial cushions
We have shown that the E12.5 atrioventricular endocardial
cushions and the structures they give rise to, the atrioventricular
valves and septa, are underdeveloped in EphA3−/− embryos and
neonates. While their reduction in size might be attributed
wholly to EMT and migration abnormalities in the developing
atrioventricular endocardial cushions, decreased proliferationand/or increased apoptosis in EphA3−/− endocardial cushion
cells could also be contributing factors. To investigate these
possibilities we compared the levels of BrdU incorporation and
the number of TUNEL-positive cells, in wildtype and EphA3−/−
endocardial cushions at E11.5 and E12.5, respectively. In vivo
BrdU labeling did not reveal any significant difference in cell
proliferation between EphA3−/− (N=9) and wildtype (N=10)
E12.5 atrioventricular endocardial cushions (Figs. 7D, E, F).
The average percentage of TUNEL-positive cell per section
through the middle 25% of EphA3−/− atrioventricular endocar-
dial cushions was significantly greater than wildtype (1.2±
0.08% versus 0.49±0.07% TUNEL-positive cells per section,
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of apoptosis in atrioventricular endocardial cushions (Abdel-
wahid et al., 2002), the TUNEL-positive cells were almost
exclusively confined to the medial portion of the endocardial
cushion where the atrial septum attaches to the central
mesenchymal mass (Figs. 7G, H).
Discussion
Cause of death in EphA3−/− mice
The histopathology we describe indicates that EphA3−/−mice
die of pulmonary edema due to elevated cardiac filling pressures.
These elevated filling pressures are evidenced by the blood
congestion in EphA3−/− atria, lungs, and livers. Ventricular
failure is an unlikely explanation for the high cardiac filling
pressures and atrial dilatation, since the EphA3−/− animals are
normally formed at birth and mouse mutants with ventricular
failure typically die at midgestation due to forward failure
(Srivastava and Olson, 1996). Furthermore, while EphA3−/−
ventricles are histologically indistinguishable from those of
wildtype animals, EphA3−/− atrioventricular valves and septal
structures are obviously abnormal compared to wildtype. These
structures are derived from the EphA3-expressing endocardial
cushions.
The EphA3−/− atrioventricular valves have dilated annuli
and their valve leaflets give the appearance of being inadequate
to close off the atrioventricular canals. The atrioventricular
cushion-derived septum bridges the interatrial and interventric-
ular septa through fusion (Harvey, 2002). In the EphA3−/−
mutant hearts this septal area is hypoplastic which may account
for the annular dilatation of their atrioventricular canals.
Annular dilatation is itself a well-known cause of valvular
dysfunction (Gillinov and Cosgrove, 2002). Incompetent
atrioventricular valves in EphA3−/− mice would account for
their atrial enlargement and increased cardiac filling pressure.
Pulmonary congestion in EphA3−/− embryos might be kept low
because embryonic lungs are collapsed and their vascular
resistance is correspondingly high. However at birth, as the
lungs begin to inflate, pulmonary vascular resistance rapidly
falls. This falling resistance along with elevated cardiac filling
pressure would rapidly lead to pulmonary edema, due in part to
the unprepared nature of neonatal lung vasculature. Similar
complications have been noted in newborn humans with
incompetent mitral valves (Grifka and Vincent, 1998).
EphA3−/− mice were found to have significant bradycardia
(HR=297±17.9 bpm versus 396±16.3 bpm in wildtype) and a
first degree AV block, as evidenced by the prolonged PR
interval (0.06±0.006 s compared to 0.04±0.005 s in wildtype
mice). The wildtype heart rate and PR interval values are
comparable to reported standards (Chaves et al., 2003; McGuire
and Alexander, 1993). The first degree heart block could reflect
AV node dysfunction secondary to abnormal endocardial
cushion development (Smits et al., 2005) or alternatively
these conduction defects could simply be a feature of the
terminally failing heart. Importantly, electrocardiograph analy-
ses did not reveal evidence of arrhythmia or of second- or third-degree AV conduction block. Thus, it is unlikely that perinatal
death in EphA3−/− mice is attributable to conduction defects.
EphA3 signaling in development of the atrial septum
The atrial septum develops as an outgrowth from the roof
of the primitive atrium. This outgrowth, the septum primum,
grows toward the atrioventricular endocardial cushion starting
at E9 in the mouse (Harvey, 2002; Webb et al., 1998). The
leading edge of the septum primum is composed of a
thickened mesenchymal cap. The expression of EphA3 in the
mesenchymal cap of the growing septum primum, and the
dysgenesis of the septum primum, together suggest that
EphA3 signaling is required for the directed growth and
development of this structure. The large atrial septal defects
seen in EphA3−/− mice probably contribute to their cyanosis
but are almost certainly not as central to their perinatal death
as are their incompetent atrioventricular valves and the
resulting pulmonary edema.
EphA3 signaling in endocardial cushion development
The primitive heart tube consists of an inner layer of
endocardial cells and an outer layer of myocardial cells,
separated by a layer of extracellular matrix material referred to
as cardiac jelly (Eisenberg and Makrwald, 1995; Icardo and
Manasek, 1992). Endocardial cushions begin as bulges of
cardiac jelly, and arise within two regions in the primitive heart
tube: the atrioventricular canal and the ventricular outflow tract.
Thereafter, the endothelial cells lining the cushions undergo
EMT and migrate into the cardiac jelly swellings. This ordered
morphogenesis separates the common atrioventricular canal
into left and right atrioventricular canals, and gives rise to the
atrioventricular valves, the atrioventricular and membranous
interventricular septa, and contributes (along with neural crest
cells) to the semilunar valves of the outflow tracts (Icardo and
Manasek, 1992; Markwald et al., 1979a, 1977; Olson and
Srivastava, 1996).
Our observation that EphA3−/− mice have developmental
defects in their atrioventricular valves and atrial septum, is
consistent with the early expression of EphA3 in the
atrioventricular endocardial cushion tissue and the mesenchy-
mal cap of the septum primum. While EphA3 is also expressed
in the outflow tract cushion tissue, examination of EphA3−/−
mutant outflow tracts did not reveal any abnormalities (data not
shown). The greater pathology in the atrioventricular valves is
presumably due to the fact that the semilunar valves are derived
from both endocardial cushions and from neural crest cells
whereas the atrioventricular valves are derived from their
endocardial cushions alone (Kisanuki et al., 2001; Nishibatake
et al., 1987).
Our analyses clearly show that the abnormalities in EphA3−/−
valves and septa can be traced back to defective development of
the atrioventricular endocardial cushions. We have shown that
there are reduced numbers of mesenchymal cells in EphA3−/−
atrioventricular endocardial cushions and that these cushions are
underdeveloped. We suggest that the reduced size of the
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reduction in the overall size of the heart (the wildtype and
EphA3−/− ventricular volumes were not significantly different
from one another) renders the mesenchymal mass in the center
of the heart insufficient to form competent valves and septa.
This would explain the delayed fusion of the inferior and
superior atrioventricular endocardial cushions in EphA3−/−
embryos and the apparent annular dilatation in P0 EphA3−/−
mice.
Cellular mechanisms of EphA3 action in endocardial cushion
development
Our demonstration that EphA3−/− endocardial cushion
explants have a significant reduction in the number of cells
that migrate into the collagen gel suggests that the reduced
number of mesenchymal cells in EphA3−/− endocardial
cushions is due to reduced capacity of these cells to delaminate
from the endothelial lining and migrate into the cardiac jelly.
Since increased apoptosis or decreased proliferation could also
contribute to the reduced number of cells in EphA3−/−
endocardial cushions, we analyzed apoptosis and proliferation
in wildtype and EphA3−/− atrioventricular endocardial cushions.
These analyses revealed a slight increase in the percentage of
endocardial cushion cells undergoing apoptosis in EphA3−/−
endocardial cushions. However, given the overall very low
number of endocardial cushion cells undergoing apoptosis in
EphA3−/− endocardial cushions we feel it unlikely that
apoptosis accounts for the EphA3−/− phenotype. The more
dramatic reduction in cell migration demonstrated in the
EphA3−/− endocardial cushion explants provides a much more
plausible explanation for the EphA3−/− defects.
Molecular mechanisms of EphA3−/− action in endocardial
cushion development
We have shown that EphA3 and its ligand, ephrin-A1, are
expressed in groups of cells in close proximity to each other in
the developing endocardial cushions and that there are
histological and functional defects in the atrioventricular septal
structures that they form. We suggest that as endothelial cells
undergo the transition to a mesenchymal phenotype they lose
their ephrin-A1 expression and begin to express EphA3. The
loss of ephrin expression may decrease cell adhesiveness (as
ephrin-A5 activation has been shown to increase cell adhesive-
ness (Davy and Robbins, 2000; Huai and Drescher, 2001)) and
allow these cells to detach from the endothelial layer. This
process might be aided by the concomitant expression of EphA3
in these cells, which would further decrease integrin-mediated
cell attachments (as has been shown for EphA2 activation
(Miao et al., 2000)). Furthermore, since in most cases, EphA–
ephrin-A interactions mediate repulsive signals (Flanagan and
Vanderhaeghen, 1998; Holder and Klein, 1999; Noren and
Pasquale, 2004; Wilkinson, 2000), the EphA3-expressing
endocardial cushion cells undergoing EMT may be repelled
by the ephrin-A1-expressing endothelial cushion cells and
migrate into the cardiac jelly. If an endothelial cell undergoingEMT were to experience a repulsive signal from the cells that
surround it in the plane of the endothelial lining, then the net
repulsive force would be directed at right angels to the
endothelial lining. Thus the EphA3–ephrin-A1 interaction
may explain the roughly parallel alignment of the long axes
of the mesenchymal cells in the cardiac jelly at right angels to
the endothelial lining of the endocardial cushion. The lack of
EphA3 signaling in the EphA3−/− atrioventricular endocardial
cushions may therefore explain the decreased number of
endocardial cushion cells undergoing EMT and the abnormal
alignment of the mesenchymal cells that do migrate into the
cardiac jelly.
The Rho family of small GTPases are among the best
documented downstream targets of EphA receptor signaling
(Kullander and Klein, 2002; Murai and Pasquale, 2003; Noren
and Pasquale, 2004). Rho family GTPases, typified by Rho, Rac
and cdc42, have been shown to be key regulatory proteins of
cell morphology and migration promoting the formation of
stress fibers (Rho), lamellipodia (Rac) and filopodia (cdc42)
(Nobes and Hall, 1995). Attempts to demonstrate Rho
activation in endocardial cushion cells were unsuccessful due
to the poor protein yields from such small structures however
we suggest that the disorganization and near-absence of stress
fibers in the majority of EphA3−/− endocardial cushion cells
may be due to decreased Rho activity.
It is interesting to consider why perinatal mortality is only
partially penetrant in EphA3−/− pups. TGFβ, which has long
been known to stimulate endocardial cushion EMT (Came-
nisch et al., 2002; Nakajima et al., 2000), has been shown to
signal through Rho to effect EMT in a variety of cell types
(Bhowmick et al., 2001; Kaartinen et al., 2002; Masszi et al.,
2003). Thus we suggest that a critical threshold of Rho
activation is necessary for endocardial cushion cells to
undergo EMT and that both TGFβ and EphA3 signaling
contribute to Rho activation. We hypothesize that in the
absence of EphA3, Rho activation reaches this critical
threshold in fewer endocardial cushion cells and therefore
fewer cells undergo EMT. The incomplete penetrance of
mortality in the EphA3−/− mice may therefore be explained
by stochastic variation in the number of endocardial cushion
cells reaching the required level of Rho activation necessary
for EMT in different EphA3−/− embryos.
In summary, the critical role of EphA3 in cardiac
development is confirmed by the severe cardiac malformations
observed in the EphA3 knockouts. The morphogenetic events in
endocardial cushion development depend on sustained signals
that induce cell migration and differentiation (Eisenberg and
Makrwald, 1995). Though contact guidance and chemotaxis
have been implicated in the control of cushion cell migration
(Markwald et al., 1979a, 1979b), no candidate molecules
controlling this directed cell movement have been put forward
nor have genes essential to the development of the atrial septum
yet been identified. We have shown that EphA3 and ephrin-A1
are expressed in complementary patterns in the endocardial
cushions and atrial septa and that EphA3 null mutants have
abnormalities in the development of these structures. Our results
therefore demonstrate that EphA3 signaling is a critical
78 L.J. Stephen et al. / Developmental Biology 302 (2007) 66–79mediator of the morphogenetic signals that control endocardial
cushion and atrial septa development.
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